Search and analyze individual stocks with comprehensive metrics

Tyche Industries Ltd

TYCHEPharmaceuticals
115.00+0.00 (+0.00%)
As on 20 Jan 2026, 11:08 amMarket Closed

Fundamental Score

...

Tyche Industries Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

9.41%
Poor

Return on Capital Employed

12.67%
Excellent

Operating Profit Margin (5Y)

21.59%
Good

Dividend Yield

2.48%

Valuation Metrics

Excellent

Price to Earnings

12.88x

Market Capitalization

124.08 (Cr)

Industry P/E

31.77x

Growth Metrics

Poor

YoY Quarterly Profit Growth

-66.30%
Poor

YoY Quarterly Sales Growth

-31.06%
Poor

Sales Growth (5Y)

-2.34%
Poor

EPS Growth (5Y)

-6.73%
Poor

Profit Growth (5Y)

-6.73%

Financial Health

Excellent

Debt to Equity

0.00x

Interest Coverage

N/A
Good

Free Cash Flow (5Y)

34.53 (Cr)

Ownership Structure

Good

Promoter Holding

61.97%
Poor

FII Holding

0.00%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
61.97%
Promoter Holding
124.08 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of TYCHE across key market metrics for learning purposes.

Positive Indicators

6 factors identified

Strong Operating Margins (21.59%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.

Attractive Valuation (P/E: 12.88 vs Industry: 31.77)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Strong Cash Generation (₹34.53 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (61.97%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

7 factors identified

Below-Average Return on Equity (9.41%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Profit Decline Concern (-66.30%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.

Revenue Contraction (-31.06%)

Observation: Sales decline may indicate market challenges or competitive pressures.

Analysis: Negative revenue growth requires analysis of market conditions and competitive positioning. Monitor recovery strategies.

Limited Growth History (-2.34% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.

Weak Earnings Growth (-6.73% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.

Stagnant Profit Growth (-6.73% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity. Assess transformation initiatives.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

Loading Peer Comparison

Finding companies in the Pharmaceuticals sector...

Financial Statements

Comprehensive financial data for Tyche Industries Ltd

About TYCHE

Business Overview

Tyche Industries Limited manufactures and sells active pharmaceutical ingredients and intermediates in India and internationally. The company also provides chiral intermediates and nutraceuticals; and contract drug substance and analytical development, as well as contract development, manufacturing, and analytical development services. It primarily exports its products to the United States and Europe. Tyche Industries Limited was incorporated in 1998 and is based in Hyderabad, India.

Company Details

Symbol:TYCHE
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Gokaraju Sandeep Kumar
Chairman & MD
Mr. Y. Srinivasa Rao
Chief Financial Officer
Mr. Pradosh Ranjan Jena
Company Secretary & Compliance Officer

TYCHE Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)9.41%
Return on Capital Employed12.67%
Operating Profit Margin (5Y)21.59%
Debt to Equity Ratio0.00
Interest Coverage RatioN/A

Growth & Valuation

Sales Growth (5Y)-2.34%
Profit Growth (5Y)-6.73%
EPS Growth (5Y)-6.73%
YoY Quarterly Profit Growth-66.30%
YoY Quarterly Sales Growth-31.06%

Frequently Asked Questions

What is the current price of Tyche Industries Ltd (TYCHE)?

As of 20 Jan 2026, 11:08 am IST, Tyche Industries Ltd (TYCHE) is currently trading at ₹115.00. The stock has a market capitalization of ₹124.08 (Cr).

Is TYCHE share price Overvalued or Undervalued?

TYCHE is currently trading at a P/E ratio of 12.88x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.

What factors affect the Tyche Industries Ltd share price?

Key factors influencing TYCHE's price include its quarterly earnings growth (Sales Growth: -31.06%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Tyche Industries Ltd a good stock for long-term investment?

Tyche Industries Ltd shows a 5-year Profit Growth of -6.73% and an ROE of 9.41%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.

How does Tyche Industries Ltd compare with its industry peers?

Tyche Industries Ltd competes with major peers in the Pharmaceuticals. Investors should compare TYCHE's P/E of 12.88x and ROE of 9.41% against the industry averages to determine its competitive standing.

What is the P/E ratio of TYCHE and what does it mean?

TYCHE has a P/E ratio of 12.88x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹13 for every ₹1 of annual earnings.

How is TYCHE performing according to Bull Run's analysis?

TYCHE has a Bull Run fundamental score of 33.6/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does TYCHE belong to?

TYCHE operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Tyche Industries Ltd.

What is Return on Equity (ROE) and why is it important for TYCHE?

TYCHE has an ROE of 9.41%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Tyche Industries Ltd generates profits from shareholders' equity.

How is TYCHE's debt-to-equity ratio and what does it indicate?

TYCHE has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.

What is TYCHE's dividend yield and is it a good dividend stock?

TYCHE offers a dividend yield of 2.48%, which means you receive ₹2.48 annual dividend for every ₹100 invested.

How has TYCHE grown over the past 5 years?

TYCHE has achieved 5-year growth rates of: Sales Growth -2.34%, Profit Growth -6.73%, and EPS Growth -6.73%.

What is the promoter holding in TYCHE and why does it matter?

Promoters hold 61.97% of TYCHE shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is TYCHE's market capitalization category?

TYCHE has a market capitalization of ₹124 crores, placing it in the Small-cap category.

How volatile is TYCHE stock?

TYCHE has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for TYCHE?

TYCHE has a 52-week high of ₹N/A and low of ₹N/A.

What is TYCHE's operating profit margin trend?

TYCHE has a 5-year average Operating Profit Margin (OPM) of 21.59%, indicating the company's operational efficiency.

How is TYCHE's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of -31.06% and YoY Profit Growth of -66.30%.

What is the institutional holding pattern in TYCHE?

TYCHE has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.